PE ratio relative to earnings growth — is the valuation justified?
| Symbol | Company | PEG | P/E | Growth | vs MMSI |
|---|---|---|---|---|---|
| RMD | ResMed Inc. | 0.81 | 21.2 | 26.1% | -43% |
| ALC | Alcon Inc. | 1.34 | 55.8 | 41.7% | -6% |
| ATR | AptarGroup, Inc. | 1.84 | 23.0 | 12.5% | +30% |
| HAE | Haemonetics Corporation | 5.04 | 27.6 | 5.5% | +254% |
| WST | West Pharmaceutical Services, Inc. | 5.64 | 44.3 | 7.9% | +297% |